Subscribe for stories that matter!
In 2011, the U.S. Department of Defense and the Environmental Protection Agency confirmed toxic chemicals were in the Naval Air Station Joint Reserve Base…
Lumberville-based Advent Therapeutics has landed a $3 million grant from the National Institute of Health to advance its treatment for preventing a rare lung…
Kannalife Sciences, a subsidiary of Neuropathix, Inc., was awarded a $2.97 million grant from the National Institutes of Health’s National Institute of Neurological…
Neuropathix, Inc., a pain management life sciences company in Doylestown, has appointed pharmaceutical industry veteran Michael Ropacki, PhD, to its scientific advisory board.
Ropacki is…
Before we send you to this site, please subscribe to our daily newsletter.